BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

BioTech Health X

502 posts

Biotech NewsCandel Therapeutics (CADL) Boosts Cash to $217M, Prepares for 2026 Prostate Cancer Launch

  • BioTech Health X
  • October 15, 2025
Candel Therapeutics, Inc. (NASDAQ:CADL) is a clinical-stage biopharmaceutical company pioneering the next generation of cancer immunotherapies by harnessing…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTeladoc (TDOC)’s AI Upgrade Could Be Its Biggest Breakthrough Since Livongo

  • BioTech Health X
  • October 15, 2025
Teladoc Health Inc. (NYSE:TDOC) is a global leader in virtual healthcare and telemedicine, widely recognized as the company…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTonix Pharmaceuticals (TNXP) Plunges 20% After FDA Win

  • BioTech Health X
  • October 14, 2025
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) is a clinical-stage biopharmaceutical company headquartered in Chatham, New Jersey, dedicated to discovering,…
0 Shares
0
0
0
0
0
0
0

Biotech NewsAstraZeneca (AZN) Targets $80 Billion Revenue by 2030

  • BioTech Health X
  • October 14, 2025
AstraZeneca PLC (NASDAQ:AZN) is one of the world’s largest and most influential biopharmaceutical companies, built on a legacy…
0 Shares
0
0
0
0
0
0
0

Biotech NewsAkero Therapeutics (AKRO) Soars 16.52% After Liver Drug Breakthrough Shocks Wall Street

  • BioTech Health X
  • October 14, 2025
Akero Therapeutics, Inc. (NASDAQ:AKRO) is a clinical-stage biotechnology company headquartered in South San Francisco, California, focused on developing…
0 Shares
0
0
0
0
0
0
0

Biotech NewsMolina Healthcare (MOH) Crashes 39% in a Year

  • BioTech Health X
  • October 14, 2025
Molina Healthcare Inc. (NYSE:MOH) is a leading managed care company in the United States that provides health insurance…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTenax Therapeutics (TENX) Fully Funded Through 2027 With $105.5M Cash

  • BioTech Health X
  • October 13, 2025
Tenax Therapeutics Inc. (NASDAQ:TENX) is a late-stage clinical biopharmaceutical company committed to transforming the treatment landscape for patients…
0 Shares
0
0
0
0
0
0
0

Biotech NewsInside Galectin (GALT)’s $18 Billion Shot at Reversing Liver Cirrhosis

  • BioTech Health X
  • October 13, 2025
Galectin Therapeutics Inc. (NASDAQ:GALT) is a clinical-stage biotechnology company headquartered in Norcross, Georgia, pioneering the development of novel…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTvardi Therapeutics (TVRD) Could Be 2025’s Most Democratic Biotech Stock

  • BioTech Health X
  • October 13, 2025
Tvardi Therapeutics, Inc. (NASDAQ:TVRD) is a clinical-stage biotechnology company redefining the boundaries of targeted therapy through its pioneering…
0 Shares
0
0
0
0
0
0
0

Biotech NewsAnavex (AVXL) Gains as $120M Cash Fuels Next Alzheimer’s & Schizophrenia Trials

  • BioTech Health X
  • October 13, 2025
Anavex Life Sciences Corp. (NASDAQ:AVXL) is a cutting-edge clinical-stage biopharmaceutical company focused on discovering and developing novel therapies…
0 Shares
0
0
0
0
0
0
0

Biotech NewsAldeyra Therapeutics (ALDX) Falls Below $5.40 as FDA Decision Looms

  • BioTech Health X
  • October 12, 2025
Aldeyra Therapeutics Inc. (NASDAQ:ALDX) is a Massachusetts-based clinical-stage biotechnology company focused on discovering and developing novel therapies designed…
0 Shares
0
0
0
0
0
0
0

Biotech NewsFresenius Medical (FMS) Hovers Near $22 — But For How Long?

  • BioTech Health X
  • October 12, 2025
Fresenius Medical Care AG (NYSE:FMS) is the world’s leading provider of dialysis products and services for individuals with…
0 Shares
0
0
0
0
0
0
0

Biotech NewsLabcorp (LH) Trades Near $210 as Investors Bet on 82% Earnings Boom

  • BioTech Health X
  • October 12, 2025
Laboratory Corporation of America Holdings (NYSE: LH), commonly known as Labcorp, is one of the world’s leading global…
0 Shares
0
0
0
0
0
0
0

Biotech NewsAxogen (AXGN) Surges Toward $26 Target as Nerve Repair Demand Soars 17%

  • BioTech Health X
  • October 12, 2025
Axogen Inc. (NASDAQ:AXGN) is a leading regenerative medicine company focused on advancing the science and clinical practice of…
0 Shares
0
0
0
0
0
0
0

Biotech NewsEmergent BioSolutions (EBS) Faces Investor Pressure After Revenue Drops to $0.81B TTM

  • BioTech Health X
  • October 10, 2025
Emergent BioSolutions Inc. (NYSE:EBS) is a global life sciences company headquartered in Gaithersburg, Maryland, known for developing, manufacturing,…
0 Shares
0
0
0
0
0
0
0

Biotech NewsAclarion (ACON) Emerges as Rising Star in AI Diagnostics at HLTH 2025 Awards

  • BioTech Health X
  • October 10, 2025
Aclarion, Inc. (NASDAQ:ACON) is a healthcare technology company pioneering the use of advanced biomarkers and augmented intelligence to…
0 Shares
0
0
0
0
0
0
0

Biotech NewsUnitedHealth (UNH) Posts $111.62B Q2 Revenue But Earnings Disappoint

  • BioTech Health X
  • October 10, 2025
UnitedHealth Group Incorporated (NYSE:UNH) stands as one of the largest and most influential healthcare companies in the world,…
0 Shares
0
0
0
0
0
0
0

Biotech NewsQuoin Pharmaceuticals (QNRX) Soars 138% After $104.5M Funding Deal

  • BioTech Health X
  • October 10, 2025
Quoin Pharmaceuticals Ltd. (NASDAQ:QNRX) is a late clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative therapies…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • X4 Pharma (XFOR) Targets 44% Annual Growth as Analysts See Upside
  • Tenax (TENX) Could Be the Best-Funded Microcap in Biotech
  • Capricor Therapeutics (CAPR) Near All-Time Lows
  • Windtree (WINT) Targets Profitability After Eliminating $8.8M in R&D Costs
  • Sight Sciences (SGHT) Surges 37% in One Month
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • October 20, 2025
    X4 Pharma (XFOR) Targets 44% Annual Growth as Analysts See Upside
    • October 20, 2025
    Tenax (TENX) Could Be the Best-Funded Microcap in Biotech
    • October 20, 2025
    Capricor Therapeutics (CAPR) Near All-Time Lows
    • October 20, 2025
    Windtree (WINT) Targets Profitability After Eliminating $8.8M in R&D Costs
    • October 19, 2025
    Sight Sciences (SGHT) Surges 37% in One Month
Recent Posts
  • SELLAS (SLS) Surged 40% After Hours on New AML Data
    • October 19, 2025
  • Artiva Biotherapeutics (ARTV) Rockets 116% in One Day
    • October 19, 2025
  • Addex Therapeutics (ADXN) Targets $330 Million Milestone Payouts
    • October 19, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (491)
  • Uncategorized (1)
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top